Is Align Technology Inc (ALGN) overvalued? · P/E 35, rev $4.00B
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
This page asks whether Align Technology Inc (ALGN) looks expensive on cached numbers — not a short thesis.
Latest reported ALGN revenue for 2024-12-31 was $4.00B. Net income was $421.4M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ALGN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ALGN stock page for the full model, not this heading.
Not investment advice.